Trial Profile
A phase II prospective non-comparative multicenter clinical trial to determine the efficacy and safety of intrathecal liposomal cytarabine (DepoCyte) in preventing CNS-relapse in patients with aggressive Non-Hodgkin-Lymphomas treated with either R-CHOP 14 or R-CHOP 21 at risk for CNS metastasis.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 05 Jul 2011
Price :
$35
*
At a glance
- Drugs Cytarabine (Primary)
- Indications Meningeal carcinomatosis; Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- Sponsors Mundipharma International
- 05 Jul 2011 New trial record